Delos Reyes, Mark Harvey M.
HRN: 22-35-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/30/2022
01/05/2023
IVT
415
Q6h
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes